Thompson, MG, et al.
Estimates of deaths associated with seasonal influenza – United States, 1976–2007. Morbidity and Mortality Weekly Report
2010; 59: 1057–1062.
Fiore, AE, et al.
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Morbidity and Mortality Weekly Report
2010; 59: RR-8.
Osterholm, MT, et al.
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infectious Diseases
2012; 12: 36–44.
Reichert, TA, et al.
The Japanese experience with vaccinating schoolchildren against influenza. New England Journal of Medicine
2001; 344: 889–896.
Simonsen, L, et al.
Impact of influenza vaccination on seasonal mortality in the US elderly population. Archives of Internal Medicine
2005; 165: 265–272.
Bodewes, R, Kreijtz, JHCM, Rimmelzwaan, GF. Yearly influenza vaccinations: a double-edged sword?
Lancet Infectious Diseases
2009; 9: 784–788.
Skowronski, DM, et al.
Association between the 2008–09 seasonal influenza vaccine and pandemic H1N1 illness during spring–summer 2009: Four observational studies from Canada. PLoS Medicine
2010; 7: e1000258.
Bodewes, R, et al.
Annual vaccination against influenza virus hampers development of virus-specific CD8+ T cell immunity in children. Journal of Virology
2011; 85: 11995–12000.
Bodewes, R, et al.
Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine
2012; 30: 7407–7410.
Ohmit, SE, et al.
Influenza vaccine effectiveness in the community and the household. Clinical Infectious Diseases
2013; 56: 1363–1369.
McLean, HQ, et al.
Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clinical Infectious Diseases
2014; 59: 1375–85.
Ohmit, SE, et al.
Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clinical Infectious Diseases
2014; 58: 319–27.
Ohmit, SE, et al.
Influenza vaccine effectiveness in households with children during the 2012–2013 season: assessments of prior vaccination and serologic susceptibility. Journal of Infectious Diseases
2015; 211: 1519–28.
Keitel, WA, Cate, TR, Couch, RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. American Journal of Epidemiology
1988; 127: 353–364.
Voordouw, ACG, et al.
Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. Journal of the American Medical Association
2004; 292: 2089–2095.
Smith, DJ, et al.
Variable efficacy of repeated annual influenza vaccination. Proceedings of the National Academy of Sciences USA
1999; 96: 14001–14006.
Carrat, F, et al.
Repeated influenza vaccination of healthy children and adults: borrow now, pay later?
Epidemiology and Infection
2006; 134: 63–70.
Longini, IM, Halloran, ME. Strategy for distribution of influenza vaccine to high-risk groups and children. American Journal of Epidemiology
2005; 161: 303–306.
Bansal, S, Pourbohloul, B, Meyers, LA. A comparative analysis of influenza vaccination programs. PLoS Medicine
2006; 3: e387.
Medlock, J, Galvani, AP. Optimizing influenza vaccine distribution. Science
2009; 325: 1705–1708.
Glasser, J, et al.
Evaluation of targeted influenza vaccination strategies via population modeling. PLoS ONE
2010; 5: e12777.
Fung, IC-H, Antia, R, Handel, A. How to minimize the attack rate during multiple influenza outbreaks in a heterogeneous population. PLoS ONE
2012; 7: e36573.
Yamin, D, et al.
An innovative influenza vaccination policy: targeting last season's patients. PLoS Computational Biology
2014; 10: e1003643.
Bansal, S, Meyers, LA. The impact of past epidemics on future disease dynamics. Journal of Theoretical Biology
2012; 309: 176–184.
Bansal, S, et al.
The shifting demographic landscape of pandemic influenza. PLoS ONE
2010; 5: e9360.
Lu, P-J, et al.
Surveillance of influenza vaccination coverage – United States, 2007–08 through 2011–12 influenza seasons. Morbidity and Mortality Weekly Report
2014; 62: SS-4 1–28.
Ferrari, MJ, et al.
Network frailty and the geometry of herd immunity. Proceedings of the Royal Society of London, Series B: Biological Sciences. 2006; 273: 2743–2748.
Lloyd-Smith, JO, et al.
Superspreading and the effect of individual variation on disease emergence. Nature
2005; 438: 355–359.
Meyers, L, et al.
Network theory and SARS: predicting outbreak diversity. Journal of Theoretical Biology
2005; 232: 71–81.
Barclay, VC, et al.
Positive network assortativity of influenza vaccination at a high school: Implications for outbreak risk and herd immunity. PLoS ONE
2014; 9: e87042.
O'Malley, AJ, et al.
Egocentric social network structure, health, and pro-social behaviors in a national panel study of Americans. PLoS ONE
2012; 7: e36250.
Xakellis, GC. Predictors of influenza immunization in persons over age 65. Journal of the American Board of Family Practice
2005; 18: 426–433.
Szilagyi, PG, et al.
Effect of patient reminder/recall interventions on immunization rates: a review. Journal of the American Medical Association
2000; 284: 1820–1827.
Bansal, S, Grenfell, BT, Meyers, LA. When individual behavior matters: homogeneous and network models in epidemiology. Journal of the Royal Society Interface
2007; 4: 879–891.
Couch, RB, Kasel, JA. Immunity to influenza in man. Annual Review of Microbiology
1983; 37: 529–549.
Pease, C. An evolutionary epidemiological mechanism, with applications to type A influenza. Theoretical Population Biology
1987; 31: 422–452.
Finkenstädt, B, Morton, A, Rand, D. Modelling antigenic drift in weekly flu incidence. Statistics in Medicine
2005; 24: 3447–3461.
Cowling, BJ, et al.
Incidence of influenza virus infections in children in Hong Kong in a 3-year randomized placebo-controlled vaccine study, 2009–2012. Clinical Infectious Diseases
2014; 59: 517–524.
Belongia, EA, et al.
Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine
2015; 33: 246–251.
Govaert, ME, et al.
The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. Journal of the American Medical Association
1994; 272: 1661–1665.
Murasko, DM, et al.
Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Experimental Gerontology
2002; 37: 427–439.
Jefferson, T, et al.
Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet
2005; 365: 773–780.
Jefferson, T, et al.
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet
2005; 366: 1165–1174.
Nichol, KL. Efficacy and effectiveness of influenza vaccination. Vaccine
2008; 26S: D17–D22.
Ambrose, CS, Levin, MJ, Belshe, RB. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza and Other Respiratory Viruses
2010; 5: 67–75.
Jackson, LA, et al.
Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infectious Diseases
2010; 10: 71.
Centers for Disease Control and Prevention. Table: Self-reported influenza vaccination coverage trends 1989–2008 among adults by age group, risk group, race/ethnicity, health-care worker status, and pregnancy status, United States, National Health Interview Survey (NHIS). (http://www.cdc.gov/flu/pdf/professionals/nhis89_08fluvaxtrendtab.pdf). 2012.
Cox, RJ, Brokstady, KA, Ograz, P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scandinavian Journal of Immunology
2004; 59: 1–15.
Gill, PW, Murphy, AM. Naturally acquired immunity to influenza type A: a clinical and laboratory study. Medical Journal of Australia
1976; 2: 329–333.
Uddin, M, et al.
Demographic and socioeconomic determinants of influenza vaccination disparities among university students. Journal of Epidemiology and Community Health
2010; 64: 808–813.